| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.0031 | 1 |